Press release
Parkinson's Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AbbVie, Alkahest, Anavex, Annovis, Aptinyx, AstraZeneca, Athira Pharma, Biogen, BioVie, CuraSen, Modag
"Parkinson's Disease Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Parkinson's Disease Therapeutics Market.
The report provides a detailed description of the Parkinson's Disease drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Parkinson's Disease Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/parkinsons-disease-pipeline-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Parkinson's Disease Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Parkinson's Disease therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Parkinson's Disease treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Parkinson's Disease drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Parkinson's Disease treatment market.
Learn More about the Clinical and Commercial Development Activities in the Parkinson's Disease Therapeutics Domain:
https://www.delveinsight.com/report-store/parkinsons-disease-pipeline-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Parkinson's Disease Therapeutics Analysis
The therapies for Parkinson's disease are categorized into multiple groups that include levodopa, carbidopa-levodopa combination, dopamine agonists, MAO B inhibitors (AZILECT, XADAGO), catechol o-methyltransferase (COMT) inhibitors, anticholinergics, adenosine A2a antagonists (ISTRADEFYLLINE), and amantadine (GOCOVRI, OSMOLEX ER). The treatment is given based on the stages of the disease, symptoms shown, and those who are already receiving some medication. Based on the mentioned criteria, the treatment can be classified into early-stage, late-stage, and non-motor symptoms.
There are approx. 140+ key companies developing therapies for Parkinson's disease. Currently, Cerevel Therapeutics is leading the therapeutics market with its Parkinson's disease drug candidates in the most advanced stage of clinical development.
Parkinson's Disease Companies in the Therapeutics Market Include:
1ST Biotherapeutics, Inc., AbbVie, Alkahest, Inc., Anavex Life Sciences Corp., Annovis Bio Inc., Aptinyx, AstraZeneca, Athira Pharma, Biogen, BioVie Inc., BlueRock Therapeutics, Brain Neurotherapy Bio, Inc., Cerevance Beta, Inc., Cerevel Therapeutics, CuraSen Therapeutics, Inc., H. Lundbeck A/S, Inhibikase Therapeutics, InnoMedica Schweiz AG, Integrative Research Laboratories AB, Intra-Cellular Therapies, Inc., Kissei Pharmaceutical Co., Ltd., Living Cell Technologies, Luye Pharma Group, MedImmune, Modag, Neuraly, NeuroDerm Ltd., Nobilis Therapeutics Inc., Novo Nordisk A/S, Peptron, Pharma Two B, Roche, Serina Therapeutics, Shanghai WD Pharmaceutical Co., Ltd., Sumitomo Pharma Co., Ltd., Sun Pharma Advanced Research Company Limited, Taiwan Mitochondrion Applied Technology Co., Ltd., Takeda, UCB Biopharma SRL, United Neuroscience Ltd., VistaGen Therapeutics, Inc., Xoc Pharmaceuticals, XWPharma, and many others.
Emerging and Marketed Parkinson's Disease Therapies Covered in the Report Include:
• ABBV-951: AbbVie
• Azilect: Teva Pharmaceuticals
• Dipraglurant: Addex Pharma S.A.
• Duopa (Carbidopa and Levodopa- ES): AbbVie
• Gocovri: Adamas Pharmaceuticals
• Haruropi Tape (Ropinirole HCL Transdermal Patch): Hisamitsu Pharmaceutical Co. Inc.
• IkT-148009: Inhibikase Therapeutics
• Inbrija (Levodopa): Acorda Therapeutics Inc.
• IPX203: Amneal Pharmaceuticals
• Kynmobi: Sunovion Pharmaceuticals
• Mesdopetam: Ipsen
• Mesdopetam/IRL790: Integrative Research Laboratories AB
• ND0612: Mitsubishi Tanabe Pharma
• NLY01: Neuraly
• Nourianz (Istradefylline): Kyowa Kirin
• Nuplazid (Pimavanserin): Acadia Pharmaceuticals, Inc.
• Ongentys: Neurocrine Biosciences
• Osmolex ER: Adamas Pharmaceutical
• P2B001: Pharma Two B
• Posiphen: Annovis Bio Inc.
• PT320: Peptron
• Tavapadon (CVL-751/PF-06649751): Cerevel Therapeutics
• Tavapadon: Cerevel Therapeutics
• Xadago (Safinamide): Newron Pharmaceuticals
And many more
Get an in-depth Assessment of the Emerging Therapies and Parkinson's Disease Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/parkinsons-disease-pipeline-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Parkinson's Disease Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Parkinson's disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Request for Sample PDF to Understand More About the Parkinson's Disease Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/parkinsons-disease-pipeline-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Parkinson's Disease Current Treatment Patterns
4. Parkinson's Disease - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Parkinson's Disease Late-Stage Products (Phase-III)
7. Parkinson's Disease Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Parkinson's Disease Discontinued Products
13. Parkinson's Disease Product Profiles
14. Parkinson's Disease Companies
15. Parkinson's Disease Drugs
16. Dormant and Discontinued Products
17. Parkinson's Disease Unmet Needs
18. Parkinson's Disease Future Perspectives
19. Parkinson's Disease Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/parkinsons-disease-pipeline-insights?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Preeclampsia Market
https://www.delveinsight.com/report-store/preeclampsia-market
Chronic Periodontitis Market
https://www.delveinsight.com/report-store/chronic-periodontitis-market
Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market
Exocrine Pancreatic Insufficiency Market
https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-market
Papilloma MarketRespiratory Distress Syndrome Market
https://www.delveinsight.com/report-store/respiratory-distress-syndrome-market
Sinusitis Market
https://www.delveinsight.com/report-store/sinusitis-market
Childhood Atropine For Myopia Progression Market
https://www.delveinsight.com/report-store/childhood-atropine-for-myopia-progression-market
Cushing's Syndrome Market
https://www.delveinsight.com/report-store/cushings-syndrome-market
Skin Burns Market
https://www.delveinsight.com/report-store/skin-burns-market
Adeno-Associated Virus Vectors in Gene Therapy Market
https://www.delveinsight.com/report-store/adeno-associated-virus-vectors-in-gene-therapy-market
Autism Spectrum Disorder Market
https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Fragile X Syndrome (FXS) Market
https://www.delveinsight.com/report-store/fragile-x-syndrome-fxs-market
Lymphedema Market
https://www.delveinsight.com/report-store/lymphedema-market
Optic Neuropathy Market
https://www.delveinsight.com/report-store/optic-neuropathy-market
Nicotine Addiction MarketDiverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market
Sinus Dilation Devices Market
https://www.delveinsight.com/report-store/sinus-dilation-devices-market
Von Willebrand disease (VWD) Market
https://www.delveinsight.com/report-store/von-willebrand-disease-vwd-market
Type 2 Diabetes Market
https://www.delveinsight.com/report-store/type-2-diabetes-market
Bone Resorption Market
https://www.delveinsight.com/report-store/bone-resorption-market
Peptic Ulcers Market
https://www.delveinsight.com/report-store/peptic-ulcers-market
Castration-Resistant Prostate Cancer (CRPC) Market
https://www.delveinsight.com/report-store/castration-resistant-prostate-cancer-crpc-market
Dysmenorrhea Market
https://www.delveinsight.com/report-store/dysmenorrhea-market
HDAC Inhibitors Market
https://www.delveinsight.com/report-store/hdac-inhibitors-market
Iron Deficiency Anemia Market
https://www.delveinsight.com/report-store/iron-deficiency-anemia-market
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market
https://www.delveinsight.com/report-store/chronic-inflammatory-demyelinating-polyneuropathy-cidp-market
Myelodysplastic Syndrome Market
https://www.delveinsight.com/report-store/myelodysplastic-syndrome-market
Sacral Nerve Stimulator Devices Market
https://www.delveinsight.com/report-store/sacral-nerve-stimulator-devices-market
Graft Versus Host Disease Market
https://www.delveinsight.com/report-store/graft-versus-host-disease-gvhd-market
Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market
Artificial Disc Market
https://www.delveinsight.com/report-store/artificial-disc-market
Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market
Bone Neoplasms Market
https://www.delveinsight.com/report-store/bone-neoplasms-market
Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market
Secondary Hyperparathyroidism Market
https://www.delveinsight.com/report-store/secondary-hyperparathyroidism-market
Fetal Monitoring Devices Market
https://www.delveinsight.com/report-store/fetal-monitoring-devices-market
Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market
Interspinous Spacers Market
https://www.delveinsight.com/report-store/interspinous-spacers-market
Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market
Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market
Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market
Diabetic Peripheral Neuropathy Market
https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market
Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market
Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market
Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market
Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market
Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market
Prurigo Nodularis Market
https://www.delveinsight.com/report-store/prurigo-nodularis-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AbbVie, Alkahest, Anavex, Annovis, Aptinyx, AstraZeneca, Athira Pharma, Biogen, BioVie, CuraSen, Modag here
News-ID: 3247960 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Park
Adventure Theme Park Market Is Booming Worldwide : Sochi Adventure Park, Adventu …
Latest Study on Industrial Growth of Adventure Theme Park Market 2023-2028. A detailed study accumulated to offer Latest insights about acute features of the Adventure Theme Park market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends…
Adventure Theme Park Market Set for More Growth | Adventure Park, Dorset Adventu …
Advance Market Analytics published a new research publication on "Adventure Theme Park Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Adventure Theme Park market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
Adventure Theme Park Market is Going to Boom | WildPlay, Adventure Park Lubbock, …
Global Adventure Theme Park Market is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Adventure Theme Park Market. Some of the…
Adventure Theme Park Market SWOT Analysis by Key Players FUNLAND ADVENTURE PARK, …
The latest research on "Adventure Theme Park Report 2021" offered by HTF MI provides a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the "Market". Some of the Major Key Players Covered in this report are Adventure Park Usa, Adventure Park Lubbock, Adventure Park…
Theme Park and Amusement Park Market is Booming Worldwide with Hopi Hari Park, H …
The latest research on “Global Theme Park and Amusement Park Report 2021” offered by HTF MI provides a comprehensive investigation into the geographical landscape, industry size along with the revenue estimation of the business. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the “Market”.
Get Free Sample PDF including full TOC, Tables and Figures and Available customizations) in Global Theme Park…
Adventure Theme Park Market Research Capital expenditure, SWOT Analysis includin …
AMA published a new study on the Global Adventure Theme Park Market exclusive insights, Opportunities and revenue size estimation and growth factors. The Study is segmented by major and emerging countries having high potential and elaborates qualitative and quantitative information including market size breakdown by revenue and volume (if applicable).The study precisely caters drivers, restrains to capture changing market dynamics affected in current scenario. To reach market size forecast and…
